Abiopharma

🔍 SCARBROUGH MICHAEL ANTHONY (Executive)

Company: InnovAge Holding Corp. (INNV)

Report Date: 2025-05-09

Detailed Transactions and Holdings:

• Acquired 10,000 shares of Common Stock, $0.001 par value at $3.55 per share (Direct)
  Date: 2025-05-09 | Code: P | equity_swap_involved: 0 | shares_owned_after: 10,000.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 13,000 shares of Common Stock, $0.001 par value at $3.73 per share (Direct)
  Date: 2025-05-12 | Code: P | equity_swap_involved: 0 | shares_owned_after: 23,000.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 10,000 shares of Common Stock, $0.001 par value at $3.89 per share (Direct)
  Date: 2025-05-13 | Code: P | equity_swap_involved: 0 | shares_owned_after: 33,000.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.50 to $3.62, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
• F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.61 to $3.82, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
• F3: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.76 to $3.96, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.